Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
2,6-Di-Tert-Butyl-4-Methylphenol is restricted in cosmetic products under Annex III of the EU Cosmetics Regulation (EC) 1223/2009.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 70/100 (high) · high confidence.
Regional restrictions
Prevalence of BUTYLATED HYDROXYTOLUENE in our catalog (epa_cpdat).
Products
7,055
Brands
6
Typical roles
Catalog
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
EU
EC
Annex III of EU Cosmetics Regulation (EC) 1223/2009: substances which cosmetic products must not contain except subject to the restrictions laid down. Product types: a) Mouthwash b) Toothpaste c) Other leave-on and rinse-off products Maximum concentration: a) 0,001 % b) 0,1 % c) 0,8 % Other conditions: From 1 July 2023 cosmetic products containing that substance and not complying with the restrictions shall not be placed on the Union market. From 1 January 2024 cosmetic products containing that substance and not complying with the restrictions shall not be made available on the Union market.
US
EPA
EPA CPDat observed this chemical in 7055 composition records across product categories including Cleaning products and household care, Home maintenance, Specialty occupational products. EPA CPDat classifies this chemical for functional uses including Stabilizing agent, Fragrance, Preservative.
Lingette Bebe 120x
Dalaa Baby
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
US
FDA
Route: BUCCAL; Dosage form: GUM, CHEWING; Maximum daily exposure: 5 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Potency: NA
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: NA
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 0.02 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Potency: NA
US
FDA
Route: NASAL; Dosage form: SPRAY, METERED; Potency: 0.1 mg/1ml
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 1 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: 0.03 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Potency: 0.1 mg
US
FDA
Route: ORAL; Dosage form: FILM, SOLUBLE; Potency: 0.06 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 14 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION, CONCENTRATE; Potency: 0.1 mg/1ml
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 3 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 1 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Potency: 0.1 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 1 mg
US
FDA
Route: RECTAL; Dosage form: SUPPOSITORY; Maximum daily exposure: 1 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Potency: 0.13 mg
US
FDA
Route: TOPICAL; Dosage form: AEROSOL, FOAM; Maximum daily exposure: 4 mg
US
FDA
Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 1 mg
US
FDA
Route: TOPICAL; Dosage form: CREAM, AUGMENTED; Potency: 0.2 %w/w
US
FDA
Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 8 mg
US
FDA
Route: TOPICAL; Dosage form: GEL, METERED; Maximum daily exposure: 4 mg
US
FDA
Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 1000 mg
US
FDA
Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 57 mg
US
FDA
Route: TOPICAL; Dosage form: SHAMPOO; Potency: 0.1 %w/w
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Maximum daily exposure: 3 mg
US
FDA
Route: TOPICAL; Dosage form: SPRAY; Maximum daily exposure: 3 mg
US
FDA
Route: TOPICAL; Dosage form: SUSPENSION; Potency: 0.02 %w/w
US
FDA
Route: VAGINAL; Dosage form: CREAM; Potency: 0.05 %w/w
US
FDA
FDA NDC lists this ingredient in 1 active drug products and 7 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.